tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

FDMT Stock Latest News

4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
Press Releases4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
4d ago
FDMT
4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting
Press Releases4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting
12d ago
FDMT
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
Press Releases4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
1M ago
FDMT
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
Press Releases4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
1M ago
FDMT
4D Molecular Therapeutics Sinks on Latest Drug Trial
Market News4D Molecular Therapeutics Sinks on Latest Drug Trial
1M ago
FDMT
4D Molecular presents interim data from Phase 1/2 PRISM trial
The Fly4D Molecular presents interim data from Phase 1/2 PRISM trial
1M ago
FDMT
Aevitas announces asset purchase agreement with 4D Molecular
The FlyAevitas announces asset purchase agreement with 4D Molecular
1M ago
FBIO
FDMT
4D Molecular acquires rights for sCFH from Aevitas Therapeutics
The Fly4D Molecular acquires rights for sCFH from Aevitas Therapeutics
1M ago
FDMT
4DMT Acquires Complement Pathway Inhibitor Payload for 4D-175 Product Candidate for Geographic Atrophy
Press Releases4DMT Acquires Complement Pathway Inhibitor Payload for 4D-175 Product Candidate for Geographic Atrophy
1M ago
FDMT
4D Molecular price target lowered to $13 from $14 at SVB Securities
The Fly4D Molecular price target lowered to $13 from $14 at SVB Securities
2M ago
FDMT
4D Molecular reports FY22 net loss $107.5M vs. $71.3M last year
The Fly4D Molecular reports FY22 net loss $107.5M vs. $71.3M last year
3M ago
FDMT
4D Molecular Therapeutics Reports Full Year 2022 Financial Results and Operational Highlights
Press Releases4D Molecular Therapeutics Reports Full Year 2022 Financial Results and Operational Highlights
3M ago
FDMT
Wedbush upgrades Sangamo to Outperform, raises price target to $16
The FlyWedbush upgrades Sangamo to Outperform, raises price target to $16
3M ago
AVRO
FDMT
4D Molecular Therapeutics Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials & Development Plans for Fabry Disease Cardiomyopathy at WORLDSymposium™
Press Releases4D Molecular Therapeutics Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials & Development Plans for Fabry Disease Cardiomyopathy at WORLDSymposium™
3M ago
FDMT
4D Molecular to hold a conference call
The Fly4D Molecular to hold a conference call
3M ago
FDMT
4D Molecular to hold a conference call
The Fly4D Molecular to hold a conference call
3M ago
FDMT
4DMT to Present Interim Clinical Data from INGLAXA Phase 1/2 Trials of 4D-310 for Fabry Disease Cardiomyopathy at 19th Annual WORLDSymposium™
Press Releases4DMT to Present Interim Clinical Data from INGLAXA Phase 1/2 Trials of 4D-310 for Fabry Disease Cardiomyopathy at 19th Annual WORLDSymposium™
4M ago
FDMT
4D Molecular Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Press Releases4D Molecular Therapeutics to Participate in the SVB Securities Global Biopharma Conference
4M ago
FDMT
3 Stocks to Buy Today, 2/7/2023, According to Top Analysts
Stock Analysis & Ideas3 Stocks to Buy Today, 2/7/2023, According to Top Analysts
4M ago
WMS
ARCB
4D Molecular announces FDA clearance of 4D-150 IND
The Fly4D Molecular announces FDA clearance of 4D-150 IND
4M ago
FDMT
4D Molecular Therapeutics Announces FDA Clearance of IND Application for 4D-150 Genetic Medicine for the Treatment of Diabetic Macular Edema
Press Releases4D Molecular Therapeutics Announces FDA Clearance of IND Application for 4D-150 Genetic Medicine for the Treatment of Diabetic Macular Edema
4M ago
FDMT
4D Molecular initiated with an Outperform at BMO Capital
The Fly4D Molecular initiated with an Outperform at BMO Capital
4M ago
FDMT